A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA

Main|Home|PHGKB

Tumor cell from a patient with triple-negative breast cancer after treatment.

Credit: National Cancer Institute

Breast Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Nov 15, 2018

---

• A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA.  
  Salta Sofia et al. Journal of clinical medicine 2018 Nov 7(11)
• A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico.  
  Diaz-Zabala Hector J et al. Cancers 2018 Nov 10(11)
• Applying new Magee equations for predicting the Oncotype Dx recurrence score.  
  Sughayer Maher et al. Breast cancer (Tokyo, Japan) 2018 Sep 25(5) 597-604
• Cancer Evolution as the New Frontier of Precision Medicine.  
  Curigliano Giuseppe et al. Handbook of experimental pharmacology 2018 Nov
• Concordance with BRCA1/2 testing guidelines among women in The Health of Women (HOW) Study ® .  
  Silver Michelle I et al. Breast cancer research and treatment 2018 Nov
• CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelines.  
  Drögemöller Britt I et al. Breast cancer research and treatment 2018 Nov
• Genome-wide DNA methylation assessment of 'BRCA1-like' early-onset breast cancer: Data from the Australian Breast Cancer Family Registry.  
  Scott Cameron M et al. Experimental and molecular pathology 2018 Nov
• Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.  
  Ladd Mary Kathleen et al. Translational behavioral medicine 2018 Nov
• Reclassification of BRCA1 and BRCA2 variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort.  
  Lee Jee-Soo et al. Journal of medical genetics 2018 Nov
• [Making better use of the clinical geneticist's expertise; treating physician could request a DNA test for most cancer patients].  
  Aalfs C M et al. Nederlands tijdschrift voor geneeskunde 2017 161(0) D1525